Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2025-12-26 @ 1:58 AM
Study NCT ID:
NCT04720105
Status:
COMPLETED
Last Update Posted:
2023-10-27
First Post:
2021-01-19
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-19
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-29
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-19
First Submit QC Date:
None
Study First Post Date:
2021-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-29
Results First Submit QC Date:
None
Results First Post Date:
2023-10-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-25
Last Update Post Date:
2023-10-27
Last Update Post Date Type:
ACTUAL